News Archives


April 16, 2013	T2 Biosystems Announces Advances in Novel Hemostasis Direct Detection Program
April 15, 2013	Joule Extends Solar CO2-Conversion Platform to Produce Renewable Gasoline and Jet Fuel
April 11, 2013	Syros Pharmaceuticals Launches with $30 Million Series A Financing
April 10, 2013	BG Medicine Welcomes CE Mark for Galectin-3 Test
April 9, 2013	BIND Therapeutics Presents Positive Clinical Data at the AACR 2013 Annual Meeting for Lead Accurin Candidate, BIND-014, in Cancer Patients
April 4, 2013	Foundation Medicine and Agios Announce Diagnostic Discovery Collaboration for IDH1 and IDH2 Cancer Metabolism Programs
April 4, 2013	Receptos Files Registration Statement for Proposed Initial Public Offering
April 4, 2013	Agios Publishes Two Articles in Science Demonstrating the Effects of Mutant IDH1 and IDH2 Inhibitors in Primary Tumor Models
April 3, 2013	T2 Biosystems Announces Issuance of Patent Covering T2Candida®Assay
April 3, 2013	BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins™

Flagship Ventures